| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| W Yan, C C Wilson, J H Harin. 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells. Brain research. Developmental brain research. vol 98. issue 2. 1997-05-27. PMID:9051259. |
buspirone treatment prevented the loss of dendritic spines previously shown to follow 5-ht depletion with pca. |
1997-05-27 |
2023-08-12 |
rat |
| Y Kitamura, T Nagatan. Buspirone enhances immobility in the forced swim test in mice. Pharmacology, biochemistry, and behavior. vol 55. issue 3. 1997-05-08. PMID:8951987. |
pretreatment with the 5-ht synthesis inhibitor p-chlorophenylalanine (200 mg/kg, ip, 3 days before further drug treatment) did not alter the effects of buspirone or 8-oh-dpat. |
1997-05-08 |
2023-08-12 |
mouse |
| B Crespo Facorro, R Gomez-Hernánde. [The treatment of the resistant obsessive-compulsive disorder: an update]. Actas luso-espanolas de neurologia, psiquiatria y ciencias afines. vol 25. issue 1. 1997-04-30. PMID:9133159. |
in open-label reports, the addition of agents that enhance serotonin neurotransmission, such as lithium, tryptophan, fenfluramine, buspirone, clonazepam and other suis or tricyclic antidepressants to ongoing treatment in sui-refractory patients has yielded encouraging results. |
1997-04-30 |
2023-08-12 |
Not clear |
| H Hall, C Lundkvist, C Halldin, L Farde, V W Pike, J A McCarron, A Fletcher, I A Cliffe, T Barf, H Wikström, G Sedval. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain research. vol 745. issue 1-2. 1997-04-29. PMID:9037397. |
the labeling of human 5-ht1a receptors with [3h]way-100635 was antagonised by the addition of 5-ht1a receptor ligands, 5-ht, buspirone, pindolol or 8-oh-dpat (10 microm), leaving a very low background of non-specific binding. |
1997-04-29 |
2023-08-12 |
human |
| I M Anderson, J F Deakin, H E Mille. The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers. Psychopharmacology. vol 128. issue 1. 1997-04-15. PMID:8944409. |
we studied the effect of 3 weeks treatment with the selective serotonin reuptake inhibitor (ssri), fluvoxamine, on hormonal and psychological responses to buspirone, a 5-ht1a receptor partial agonist which also binds to dopamine receptors, in normal male volunteers. |
1997-04-15 |
2023-08-12 |
human |
| A Gobert, J M Rivet, J M Cistarelli, M J Milla. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. Journal of neurochemistry. vol 68. issue 3. 1997-04-07. PMID:9048781. |
buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. |
1997-04-07 |
2023-08-12 |
rat |
| A Gobert, J M Rivet, J M Cistarelli, M J Milla. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. Journal of neurochemistry. vol 68. issue 3. 1997-04-07. PMID:9048781. |
a serotonin (5-ht)1a receptor partial agonist, buspirone, potentiates the clinical antidepressant properties of 5-ht reuptake inhibitors (ssris). |
1997-04-07 |
2023-08-12 |
rat |
| A Gobert, J M Rivet, J M Cistarelli, M J Milla. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. Journal of neurochemistry. vol 68. issue 3. 1997-04-07. PMID:9048781. |
herein, we examined the interaction of buspirone with two ssris, duloxetine and fluoxetine, on extracellular levels of 5-ht, dopamine (da), and noradrenaline (nad) in single dialysate samples of freely moving rats. |
1997-04-07 |
2023-08-12 |
rat |
| A Gobert, J M Rivet, J M Cistarelli, M J Milla. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. Journal of neurochemistry. vol 68. issue 3. 1997-04-07. PMID:9048781. |
buspirone (2.5 mg/kg, s.c.) similarly elevated levels of da (100%) and nad (160%) but reduced those of 5-ht (-50%). |
1997-04-07 |
2023-08-12 |
rat |
| A Gobert, J M Rivet, J M Cistarelli, M J Milla. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. Journal of neurochemistry. vol 68. issue 3. 1997-04-07. PMID:9048781. |
administered with buspirone, the ability of duloxetine and fluoxetine to increase 5-ht levels was transiently inhibited (over 60 min), although by the end of sampling (180 min) their actions were fully expressed. |
1997-04-07 |
2023-08-12 |
rat |
| A Gobert, J M Rivet, J M Cistarelli, M J Milla. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats. Journal of neurochemistry. vol 68. issue 3. 1997-04-07. PMID:9048781. |
nad but not 5-ht release in fcx may contribute to their increased antidepressant activity in the presence of buspirone. |
1997-04-07 |
2023-08-12 |
rat |
| A H Lau, G D Fry. Acute and chronic actions of ethanol on CA1 hippocampal responses to serotonin. Brain research. vol 731. issue 1-2. 1997-03-25. PMID:8883849. |
5-ht (1-100 microm) caused concentration-dependent hyperpolarization of the membrane that was not altered by simultaneous 30 mm ethanol treatment, but blunted by 10 microm buspirone, a weak 5-ht1a agonist. |
1997-03-25 |
2023-08-12 |
rat |
| K Rickels, A Derivan, N Kunz, A Pallay, E Schweize. Zalospirone in major depression: a placebo-controlled multicenter study. Journal of clinical psychopharmacology. vol 16. issue 3. 1997-03-18. PMID:8784652. |
compounds active at the serotonin (5-ht)1a receptor (mostly azapirones) have shown some evidence of antidepressant effect. |
1997-03-18 |
2023-08-12 |
Not clear |
| F F Matos, C Urban, F D Yocc. Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release. Journal of neural transmission (Vienna, Austria : 1996). vol 103. issue 1-2. 1997-02-18. PMID:9026372. |
the decreases in the raphé and hippocampal 5-ht induced by systemic buspirone were antagonized in rats pretreated with 1.0 mm (-) pindolol, locally perfused into the dorsal raphé. |
1997-02-18 |
2023-08-12 |
rat |
| F F Matos, C Urban, F D Yocc. Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release. Journal of neural transmission (Vienna, Austria : 1996). vol 103. issue 1-2. 1997-02-18. PMID:9026372. |
buspirone perfusion into the dorsal raphé did not change (10 nm, 100 nm), or produced a small increase (1.0 mm) in raphé 5-ht, without changing hippocampal 5-ht. |
1997-02-18 |
2023-08-12 |
rat |
| S B Kasture, S N Mandhane, C T Chopd. Baclofen-induced catatonia: modification by serotonergic agents. Neuropharmacology. vol 35. issue 5. 1997-02-13. PMID:8887967. |
the 5-ht releaser fenfluramine (10 mg/kg) and the uptake inhibitor fluoxetine (10 mg/kg) reversed, whereas the 5-ht1a agonist buspirone (3 mg/kg) potentiated baclofen-induced catatonia. |
1997-02-13 |
2023-08-12 |
rat |
| M Van Ameringen, C Mancini, C Wilso. Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia. Journal of affective disorders. vol 39. issue 2. 1996-12-26. PMID:8827420. |
buspirone augmentation of selective serotonin reuptake inhibitors (ssris) in social phobia. |
1996-12-26 |
2023-08-12 |
Not clear |
| M Van Ameringen, C Mancini, C Wilso. Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia. Journal of affective disorders. vol 39. issue 2. 1996-12-26. PMID:8827420. |
we evaluated the efficacy of buspirone, in the augmentation of social phobic symptom response to the selective serotonin reuptake inhibitors (ssris). |
1996-12-26 |
2023-08-12 |
Not clear |
| M Carli, S Afkhami-Dastjerdian, T A Reade. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline. Journal of psychiatry & neuroscience : JPN. vol 21. issue 2. 1996-12-17. PMID:8820177. |
in competition experiments with 5-ht, buspirone, and pindolol, the curves were always best fitted to a 2-site model. |
1996-12-17 |
2023-08-12 |
rat |
| S Hjort. (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. European journal of pharmacology. vol 303. issue 3. 1996-12-11. PMID:8813565. |
(-)-pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine. |
1996-12-11 |
2023-08-12 |
rat |